Bleeding with the FXI Inhibitor Abelacimab compared with Rivaroxaban in Patients on Antiplatelet therapy: A Prespecified Analysis of the AZALEA-TIMI 71 Trial
Al Said Samer, Goodman Shaun, Joung Boyoung, Kiss Robert, Spinar Jindrich, Wojakowski Wojciech, Weitz Jeffrey, Bloomfield Dan, Sabatine Marc, Ruff Christian, Patel Siddharth, Giugliano Robert, Morrow David, Goodrich Erica, Murphy Sabina, Hug Bruce, Parker Sanobar, Chen Shih-ann
Sustained Anti-Thrombotic Efficacy of CS585, a Novel Prostacyclin Receptor Agonist, Demonstrates Therapeutic Potential
Stanger Livia, Flores Mariane, Yalavarthi Pooja, Dahlof Bjorn, Holinstat Michael
